Skip to main content

Table 1 Results from the Real World Feasibility Study [32].

From: Will availability of inhaled human insulin (Exubera®) improve management of type 2 diabetes? The design of the Real World trial

Current treatment Percentage of study patients (%) Treatment preferences (%)
    "I will NOT change my current treatment" "I am willing to consider new oral agents" "I am willing to consider SC insulin" "I am willing to consider inhaled insulin"
  Inhaled insulin available Inhaled insulin NOT available Inhaled insulin available Inhaled human insulin NOT available Inhaled insulin available Inhaled insulin NOT available Inhaled insulin available Inhaled insulin NOT available Inhaled insulin available Inhaled insulin NOT available
Diet/exercise 5.4 7.2 28.6 39.3 47.6 60.7 4.8 0 4.8 N/A
1 oral agent 32.5 36.6 26.0 41.5 33.9 43.0 5.5 14.1 30.7 N/A
2 oral agents 52.4 46.1 28.8 45.3 19.0 35.8 8.3 17.9 38.5 N/A
3 oral agents 9.7 10.1 23.7 43.6 5.3 33.3 15.3 20.5 50.0 N/A